Env-specific and V1V2-specific IgG3 response rates were shown to be somewhat lower in Vax003 than in RV144, where the V1V2-specific IgG3 response in RV144 correlated with a decreased risk of HIV-1 infection [83]. The gene discussed is IGHG3; the disease is HIV-1 infection.